While our cohort did not include confirmed pituitary tumors, the shared hormonal imbalances in PCOS and hyperprolactinemia suggest that similar mechanisms may contribute to elevated galectin-3 levels in these patients. Here, LGALS3 is linked to hyperprolactinemia.